Factors related to age at menopause among Korean women: the Korean Longitudinal Survey of Women and Families

Kim, Young Taek; Cha, Chiyoung; Lee, Mi Ran

doi:10.1097/gme.0000000000001268

Cited by 12 publications

(5 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The average age of menopause generally ranges from ~50 and 51 years [22,23]. Therefore, this study excluded women aged ≤49 years at the last clinic visit.…”

Section: Discussionmentioning

confidence: 99%

Hormone Replacement Therapy and Risks of Various Cancers in Postmenopausal Women with De Novo or a History of Endometriosis

Lee,

Choi

et al. 2024

Cancers

View full text Add to dashboard Cite

This study examined the impact of hormone replacement therapy (HRT) on the occurrence of various cancers in postmenopausal women with de novo or a history of endometriosis. In the datasets for ten cancers (cervical, uterine, ovarian, breast, colon, gastric, liver, lung, pancreatic, and thyroid), women who received HRT (the HRT group) and those who did not (the control group) were selected by a 1:1 matching with those who met the study criteria. In the dataset for each cancer, the incidence of each cancer was very low (0.2% to 1.5% in the HRT group and 0.2% to 1.3% in the control group). The duration of HRT was 1.3 ± 2.1 years. After adjusting for co-variables, HRT was a significant risk factor for uterine cancer (p < 0.05). However, the risk of liver cancer decreased significantly with duration of HRT (p < 0.05). Moreover, combined estrogen and progesterone decreased the risks of liver and thyroid cancers significantly (p < 0.05), and estrogen alone decreased the risks of breast and lung cancers significantly (p < 0.05). Tibolone was not associated with the risk of any of the cancers assessed. These results can help guide the use of HRT in women with de novo or a history of endometriosis.

show abstract

“…The average age of menopause generally ranges from ~50 and 51 years [22,23]. Therefore, this study excluded women aged ≤49 years at the last clinic visit.…”

Section: Discussionmentioning

confidence: 99%

Hormone Replacement Therapy and Risks of Various Cancers in Postmenopausal Women with De Novo or a History of Endometriosis

Lee,

Choi

et al. 2024

Cancers

View full text Add to dashboard Cite

show abstract

“…Age at menopause for Korean women is ~50 years [ 28 ]. Therefore, women aged ≤49 years at their last clinic visit were excluded from the present study.…”

Section: Discussionmentioning

confidence: 99%

Impact of Hormone Replacement Therapy on Risk of Ovarian Cancer in Postmenopausal Women with De Novo Endometriosis or a History of Endometriosis

Lee

Choi

et al. 2023

Cancers

View full text Add to dashboard Cite

The effect of hormone replacement therapy (HRT) on the malignant transformation of postmenopausal endometriosis remains unclear. This study aimed to investigate the impact of HRT on ovarian cancer occurrence in postmenopausal women with de novo endometriosis or a history of endometriosis. A total of 10,304 women that received HRT (the HRT group) and 10,304 that did not (the control group) were selected by 1:1 matching those that met the study criteria. Incidences of ovarian cancer (0.3% in the HRT group and 0.5% in the control group) and cumulative incidence rates of ovarian cancer were similar in the two groups. The overall mean duration of HRT was 1.4 ± 2.2 years, but the duration of HRT in women with ovarian cancer was 2.2 ± 2.9 years. After adjusting for co-variables, receipt of HRT, duration of HRT, combined use of estrogen and progesterone, and tibolone were not found to be risk factors for ovarian cancer. However, the use of estrogen alone was found to be a significant risk factor for ovarian cancer (HR 2.898; 95% CI 1.251–6.715; p = 0.013). With the exception of HRT using estrogen alone, HRT did not increase the risk of ovarian cancer in postmenopausal women with a history of endometriosis or de novo endometriosis.

show abstract

“…A cutoff score of 10 was used to present depressive symptoms based on studies conducted in the United States (Irwin et al, 1999) and in Korean (Shin, 2011) and East Asian samples (Boey, 1999). This cutoff score has been used with success to explore depressive symptom clusters (Cha & Nam, 2015) and their influence on menopause in Korean women (Kim et al, 2019). We used this score to distinguish between women who were and were not experiencing depressive symptoms.…”

Section: Methodsmentioning

confidence: 99%

Sexual Violence as a Key Predictor of Depressive Symptoms in Women: Korean Longitudinal Survey of Women and Families

Cha

Lee

2022

Violence Against Women

Self Cite

View full text Add to dashboard Cite

The purpose of this study was to identify the influence of violence on depressive symptoms in women. We analyzed panel data from the Korean Longitudinal Survey of Women and Families ( n = 6,632). Exposure to sexual violence was a significant predictor of the onset of depressive symptoms. After adjusting for all covariates, other predictors included the perception of a poor or very poor health status than normal and participants in their 40s and 50s versus participants younger than 40 years. Assessing exposure to sexual violence might be beneficial for evaluating depressive symptoms in women who are newly diagnosed with depression.

show abstract

Factors related to age at menopause among Korean women: the Korean Longitudinal Survey of Women and Families

Cited by 12 publications

References 29 publications

Hormone Replacement Therapy and Risks of Various Cancers in Postmenopausal Women with De Novo or a History of Endometriosis

Hormone Replacement Therapy and Risks of Various Cancers in Postmenopausal Women with De Novo or a History of Endometriosis

Impact of Hormone Replacement Therapy on Risk of Ovarian Cancer in Postmenopausal Women with De Novo Endometriosis or a History of Endometriosis

Sexual Violence as a Key Predictor of Depressive Symptoms in Women: Korean Longitudinal Survey of Women and Families

Contact Info

Product

Resources

About